In Cfh−/− mice (a model of C3 glomerulopathy, a kidney disease caused by the AP dysregulation), the ablation of C5 improves survival and reduces glomerular inflammation (mediated by C5a), but does not reduce proteinuria or glomerular C3 staining (95). The gene discussed is C5; the disease is complement 3 glomerulopathy.